Renal Failure, Chronic Clinical Trial
Official title:
Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure
The timing for arteriovenous fistula (AVF) creation and its effect on target organs in patients with chronic renal failure will be investigated by multicenter prospective cohort. Lower estimated glomerular filtration rate (eGFR) patients (eGFR<10ml/min 1.73m2 for patients without diabetic kidney disease, and eGFR<15ml/min 1.73m2 for diabetic kidney disease) and higher eGFR patients (eGFR 10-15ml/min 1.73m2 for patients without diabetic kidney disease, and eGFR 15-20ml/min 1.73m2 for diabetic kidney disease) will be proposed to undertake AVF creation. Maturation rate and time of AVF will be followed up in 3 months; primary and secondary patency rate of AVF, AVF construction on cardiac structure, function, encephalopathy, cerebral vascular lesions and cognitive function will be followed up in the next 2 years. This multicenter will provide evidence to develop guideline of timing for AVF creation
n/a
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00259025 -
Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
|
Phase 2 | |
Completed |
NCT00176059 -
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
|
Phase 0 | |
Completed |
NCT00439023 -
Glucose in Dialysis Water in Non-diabetics
|
Phase 4 | |
Completed |
NCT00438503 -
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
|
Phase 4 | |
Completed |
NCT03904836 -
Tobramycin Administered at the Beginning of Dialysis
|
Phase 1 | |
Completed |
NCT00150891 -
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
|
N/A | |
Completed |
NCT01875523 -
PK of Serelaxin in Severe Renal Impairment and ESRD
|
Phase 1 | |
Completed |
NCT00438295 -
Temperature Control During Dialysis Treatment
|
Phase 4 | |
Terminated |
NCT00664066 -
DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
|
||
Withdrawn |
NCT00262353 -
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
|
N/A |